The case for allowing performance-enhancing drugs in sports rests on several overlapping arguments: the current ban doesn’t work well, it pushes drug use underground where it becomes more dangerous, it ignores the genetic inequalities already baked into competition, and it costs tens of millions of dollars a year to enforce. None of these arguments are fringe. They’ve been advanced in publications like The Lancet and debated seriously by ethicists, physicians, and former athletes for decades.
The Fairness Argument Is More Complicated Than It Seems
Anti-doping rules are built on the idea that drug-free competition is inherently fair. But “fair” is doing a lot of heavy lifting in that sentence. Athletes arrive at the starting line with wildly different genetic gifts, and no one considers that cheating. Some people carry genetic variations that increase their respiratory capacity, boost energy production during exercise, or alter muscle protein structures in ways that make them naturally stronger. Others have sequence variations in testosterone receptor genes that let them extract more benefit from the same amount of testosterone as a less fortunate competitor.
As a viewpoint published in The Lancet put it, getting help from your genes by being blessed with a performance-enhancing genetic predisposition is acceptable, while using drugs is not, yet both types of advantage are undeserved. The anchoring of anti-doping rules in fair play is misguided when biological and environmental factors that affect performance go completely unchecked. Wealthy nations invest in altitude training camps, cutting-edge nutrition science, and recovery technology that athletes from smaller countries can’t access. The playing field was never level to begin with, and banning drugs doesn’t make it so.
The Ban Pushes Athletes Toward Dangerous Behavior
One of the strongest practical arguments for legalization is harm reduction. Right now, athletes who use performance-enhancing substances do so in secret, without medical oversight, and often with products bought from unregulated sources. A narrative review published in Medicines found that athletes frequently misuse drugs without adequate supervision, relying on unreliable information, which leads to improper dosing and serious health risks. Many acquire substances from fake online pharmacies, black market dealers, or fellow athletes. The result is counterfeit or contaminated products circulating with no quality control.
This is a pattern familiar from other areas of public health. Prohibition doesn’t eliminate demand. It just removes the safety net. If performance-enhancing substances were permitted under medical supervision, athletes could work with physicians who understand dosing, monitor blood work, screen for cardiovascular risk factors, and intervene early when something goes wrong. The substances themselves carry real risks, but so does every contact sport, every grueling training regimen, and every weight cut. The question isn’t whether the drugs are perfectly safe. It’s whether supervised use is safer than the unregulated status quo. The evidence strongly suggests it is.
Current Testing Catches a Fraction of Users
The anti-doping system is expensive and, by its own metrics, not particularly effective. The World Anti-Doping Agency ended 2024 with $45.4 million in total income and $49.3 million in operating expenses, running a $3.1 million deficit. That’s just the global agency. It doesn’t include the budgets of national anti-doping organizations, lab costs, legal proceedings, and appeals.
For all that spending, the detection rate is strikingly low. In 2021, only about 1% of the unique athletes tested by the U.S. Anti-Doping Agency were sanctioned for violations. But anonymous survey research tells a very different story. A study of elite U.S. athletes subject to drug testing found that between 6.5% and 9.2% reported using one or more prohibited substances or methods in the previous 12 months. That gap between the roughly 1% caught and the roughly 7 to 9% who admit to doping means the system penalizes a small, unlucky subset while the majority of users compete without consequence.
Testing also has fundamental technical limitations. It captures only a snapshot in time, and WADA’s Prohibited List contains hundreds of substances and methods, some of which have no effective detection method at all. Athletes with more resources can access designer compounds that stay ahead of testing. The result is a system that punishes athletes from less wealthy programs disproportionately while well-funded doping operations slip through. Legalization, proponents argue, would at least end this selective enforcement.
Faster Recovery Could Extend Careers
Performance-enhancing substances aren’t only about running faster or lifting more. Some of the most compelling use cases involve injury recovery. Animal research on muscle contusion injuries found that anabolic steroids may speed the recovery of force-generating capacity in damaged muscle. In one study, muscles treated with an anabolic steroid were significantly stronger at the 14-day mark compared to controls, while muscles treated with a common anti-inflammatory steroid (the kind already permitted in sports medicine) had totally degenerated, with disorganized fiber architecture and a dramatic loss of strength.
Professional athletes already undergo surgeries, take approved medications, and use therapies that accelerate healing far beyond what the body would manage on its own. The line between “treatment” and “enhancement” is blurry. Allowing certain substances for rehabilitation could shorten recovery timelines, reduce the career-ending potential of serious injuries, and keep athletes healthier over the long term. For fans who want to watch the best athletes compete at their peak for as long as possible, this is a practical benefit with real value.
The Spectacle Argument
Sports are entertainment, and entertainment thrives on extraordinary performances. Research on North American professional leagues shows that winning and high-level performance drive revenue in measurable ways. In Major League Baseball, the financial returns to winning increase at an increasing rate, meaning each additional win is worth more than the last. During the 1987 NFL players’ strike, when replacement players took the field, attendance dropped 55%, from an average of 54,873 to 24,551. In English soccer, promotion to a higher division brings an average 22% increase in attendance and a 44% increase in revenue, while relegation causes corresponding declines.
The lesson is straightforward: fans pay to see the best. Record-breaking performances, faster times, and more dramatic feats of athleticism generate more interest, more viewers, and more money. The “steroid era” in baseball remains one of the most commercially successful periods in the sport’s history. Whether or not you think that’s a good reason to allow drugs in sports, it’s a real economic force that shapes the debate.
Autonomy and Informed Consent
Perhaps the most fundamental argument is about personal freedom. Professional athletes accept enormous physical risks as part of their careers. Football players sustain repeated brain trauma. Gymnasts train through growth plate injuries as teenagers. Marathon runners push their cardiovascular systems to extremes. Society permits all of this because the athletes are adults who understand the risks and choose to accept them.
Banning performance-enhancing drugs treats athletes as incapable of making informed decisions about their own bodies while simultaneously allowing them to make other choices that carry equal or greater health risks. If a 28-year-old professional can consent to a career in boxing, where the explicit goal is to cause brain injury to an opponent, the argument that they can’t consent to monitored testosterone use starts to look inconsistent.
Legalization wouldn’t mean forcing anyone to use drugs. Athletes who prefer to compete without pharmaceutical assistance could still do so, just as athletes today choose different training methods, diets, and recovery protocols. The difference is that those who do choose enhancement wouldn’t be criminalized for it, and they’d have access to medical support instead of black market suppliers.
What Legalization Would Actually Require
Advocates for allowing performance-enhancing drugs don’t typically argue for a free-for-all. Most proposals involve regulated frameworks: approved substance lists, mandatory health screenings, ongoing medical monitoring, and transparent reporting. The goal is to replace a failing prohibition system with one that acknowledges reality and manages risk.
Critics rightly point out that many health consequences of these substances show up years or even decades later, and no amount of monitoring can fully prevent long-term damage. That’s a legitimate concern. But the current system already fails to prevent use. It just ensures that use happens in the dark, without oversight, with contaminated products and no medical guidance. The practical question isn’t whether performance-enhancing drugs are risk-free. It’s whether a regulated, transparent system would produce better health outcomes than the prohibition model that athletes, doctors, and anti-doping agencies have struggled with for over half a century.